Niacin: Time to Believe Outcomes Over Surrogate Outcomes: If Not Now, When?

Circ Cardiovasc Qual Outcomes. 2016 Jul;9(4):343-4. doi: 10.1161/CIRCOUTCOMES.116.003094. Epub 2016 Jul 12.

Author

Harlan M Krumholz¹

Affiliation

¹ From the Section of Cardiovascular Medicine and the Robert Wood Johnson Foundation Clinical Scholars Program, Department of Internal Medicine, Yale School of Medicine, New Haven, CT; Department of Health Policy and Management, Yale School of Public Health, New Haven, CT; and Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, CT. harlan.krumholz@yale.edu.

PMID: 27407051
DOI: 10.1161/CIRCOUTCOMES.116.003094

No abstract available

Keywords: United States; lipid; myocardial infarction; niacin; risk factor.

MeSH terms

Cholesterol, HDL
Humans
Hypolipidemic Agents / therapeutic use*
Myocardial Infarction
Niacin / therapeutic use*

Substances

Cholesterol, HDL
Hypolipidemic Agents
Niacin